Zinplava (bezlotoxumab)

bezlotoxumab · Merck & Co.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zinplava (bezlotoxumab), covering 2024-12-11 to 2024-12-11. Get the full timeline:

Most recent: Clinical Trial Update: ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI [Phase 2]